UNC Lineberger Comprehensive Cancer Center

NCT07340541

Phase 2Recruiting700 people14 Jan 2026clinicaltrials.gov

NCT07078838

Phase 2Not yet recruiting40 people22 Jul 2025clinicaltrials.gov

Tirzepatide in Obesity-Driven Endometrial Cancer

Early phase 1Recruiting20 people15 Jul 2025clinicaltrials.gov

NCT06727773

Phase 2Recruiting90 people11 Dec 2024clinicaltrials.gov

NCT06348147

Phase 2Withdrawn0 people4 Apr 2024clinicaltrials.gov

NCT05911321

Phase 2Active, not recruiting6 people22 Jun 2023clinicaltrials.gov

NCT05498220

Phase 2Terminated5 people11 Aug 2022clinicaltrials.gov

NCT05472792

Phase 2Recruiting90 people25 Jul 2022clinicaltrials.gov

NCT05366166

Phase 2Active, not recruiting45 people9 May 2022clinicaltrials.gov

NCT05145400

Phase 2Recruiting50 people6 Dec 2021clinicaltrials.gov

NCT04033419

Phase 2Completed55 people26 Jul 2019clinicaltrials.gov

NCT03620019

Phase 2Completed25 people8 Aug 2018clinicaltrials.gov

NCT02767362

Early phase 1Completed24 people10 May 2016clinicaltrials.gov

NCT02700022

Phase 1Terminated1 person7 Mar 2016clinicaltrials.gov

NCT02585973

Phase 1Completed12 people26 Oct 2015clinicaltrials.gov

NCT02281955

Phase 2Completed115 people4 Nov 2014clinicaltrials.gov

NCT02035787

Phase 2Completed20 people14 Jan 2014clinicaltrials.gov

NCT01911247

Early phase 1Completed28 people30 Jul 2013clinicaltrials.gov

NCT01859858

Phase 1Completed23 people22 May 2013clinicaltrials.gov

NCT01685762

Early phase 1Completed18 people14 Sept 2012clinicaltrials.gov